帕金森病中的外体微RNA:对生物标志物潜力和疾病病理学的洞察
Deepthy Chandran1, Syam Krishnan2, Madhusoodanan Urulangodi3
1Department of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Medical College POST, Trivandrum, Kerala, 695011, India.
概括
研究人员正在探索外体微RNA (miRNA) 作为帕金森病 (PD) 的潜在血液生物标志物. 这些微小的囊泡可能为诊断PD和查神经退行性疾病提供了一种新方法.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,特别是在老年人中.
- 目前的诊断方法缺乏可靠的基于血液的生物标志物,用于早期检测和查.
研究的目的:
- 审查外体微RNAs (miRNAs) 在帕金森病病理学中的作用.
- 评估外体miRNAs作为PD诊断和查的血液生物标志物的潜力.
主要方法:
- 文献综述侧重于外体和它们的分子载荷.
- 对在帕金森病中调查外体miRNA的研究进行分析.
- 对外体miRNAs的潜在临床实用性的评估.
主要成果:
- 外基因组通过转移像miRNAs这样的分子来促进细胞间的通信.
- 外体细胞可以穿越血脑屏障,并且存在于血清和血等体液中.
- 外体miRNA显示出作为潜在的PD生物标志物的希望,尽管挑战仍然存在.
结论:
- 外体miRNAs代表了开发帕金森病的基于血液的生物标志物的有前途领域.
- 需要进一步的研究来克服利用外体miRNAs用于精确的PD诊断的挑战.
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


